FindTrial
Sign In

â??A study to compare efficacy of two types of pain relief methods i.e injection at the operation site in the skin versus putting the medicine in the abdominal cavity combined with injection at operation post operative pain relief and effect on recovery after laproscopic cholecystectomyâ??

â??Double blind randomised control study to compare efficacy of incisional Bupivacaine Vs both intraperitoneal and incisional Bupivacaine for post operative pain relief and effect on recovery after laproscopic cholecystectomyâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/09/009875
Enrollment
60
Registered
2017-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- good

Interventions

Intervention1: combined intraperitoneal and incisional Bupivacaine: intraperitoneal instillation of 20 ml of 0.25% Bupivacaine and4-5 ml of 0.25% Bupivacaine at each site of trochar insertion with a

Sponsors

dr sanjeevani zadkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA I-II patients 2. patients undergoing Laparoscopic cholecystectomy using 3-4 ports

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Primary objective 1.post operative pain score using VISUAL ANALOGUE SCALE till 48 hrs Timepoint: Primary objective 1.post operative pain score using VISUAL ANALOGUE SCALE till 48 hrs Secondary outcomes 1.time taken for recovery to normal activity &walking around without support 2.feeling of wellbeing on ordinal scale 1-5 for first 5 days postoperatively 3. rescue analgesia requirement-no of doses and timings 4.duration of stay in recovery room in minutes 5.incidence of nausea and vomitting-in form of present or absent—

Secondary

MeasureTime frame
Secondary outcomes 1.time taken for recovery to normal activity &walking around without support 2.feeling of wellbeing on ordinal scale 1-5 for first 5 days postoperatively 3. rescue analgesia requirement-no of doses and timings 4.duration of stay in recovery room in minutes 5.incidence of nausea and vomitting-in form of present or absent Timepoint: till 5 days post op—

Countries

India

Contacts

Public ContactDr Sanjeevani Zadkar

seth G.S.Medical college &KEM Hospitals

sanjeevanizadkar@kem.edu9167151512

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026